Figures & data
Figure 1 Flowchart of data exclusions used to create the Readmission After COPD Exacerbation risk Scale.
![Figure 1 Flowchart of data exclusions used to create the Readmission After COPD Exacerbation risk Scale.](/cms/asset/444887b2-ab54-4535-bce1-0cc021f14c02/dcop_a_136768_f0001_b.jpg)
Table 1 Demographic and comorbidities data involving 339,389 COPD patients of derivation cohort
Table 2 Demographic and comorbidities data involving 258,113 COPD patients of validation cohort
Figure 2 Readmission rates by demographic and clinicopathological characteristic among COPD patients of derivation cohort.
Abbreviations: LOS, length of stay (days); CHF, congestive heart failure; PCD, pulmonary circulation disorder; FED, fluid and electrolyte disorder; PVD, peripheral vascular disease; PUD, peptic ulcer disease.
![Figure 2 Readmission rates by demographic and clinicopathological characteristic among COPD patients of derivation cohort.Abbreviations: LOS, length of stay (days); CHF, congestive heart failure; PCD, pulmonary circulation disorder; FED, fluid and electrolyte disorder; PVD, peripheral vascular disease; PUD, peptic ulcer disease.](/cms/asset/70c77556-2219-4ce9-a10b-506bea57a7e4/dcop_a_136768_f0002_c.jpg)
Figure 3 Readmission rates by demographic and clinicopathological characteristic among COPD patients of validation cohort.
![Figure 3 Readmission rates by demographic and clinicopathological characteristic among COPD patients of validation cohort.](/cms/asset/13b0e38b-a451-4e1d-abbc-1cc7590aa693/dcop_a_136768_f0003_c.jpg)
Table 3 Univariate and multivariate analysis of factors predicting readmission after COPD of derivation cohort
Table 4 Univariate and multivariate analysis of factors predicting readmission after COPD of validation cohort
Table 5 Values for components of Readmission After COPD Exacerbation (RACE) Scale